Company profile for Fareva

Fareva-PSE
News

DATA COMPILATION
#PharmaFlow

PharmaCompass

Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

Related CompaniesRelated Companies

About

Fareva’s API division has special technologies for high potent APIs (HPAPIs) down to the OEB-6 level, aseptic crystallization (sterile APIs), Spray Drying etc, with volumes ranging from a few kgs to multi tons production.
Fareva’s Drug Product division offers different technologies: injectables (lyophilized, solution, suspension, vial, ampoules, pre-filled syringes), unidoses and multidoses BFS, solids (tablets, hard capsules, powders), semi-solids (cream, gel suppositories) and liquids (oral and external, sprays, aerosols).

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Luxembourg
Address
Address
28 place de la gare, 1616 Luxembourg
Telephone
Telephone
+49 16090545489
youtube
YouTube
Twitter
Twitter
Contact Info
Others

Events

Webinars & Exhibitions

CPhI India 2024

CPhI India 2024

Not Confirmed

envelop Contact Supplier

CPhI India 2024

Post an Enquiry

Meeting

Digital content read-more

Explore the latest content creation from this company

CORPORATE CONTENT #SupplierSpotlight

    https://www.pharmacompass.com/pdf/party/content/fareva-party-content-78446.pdf

    https://www.pharmacompass.com/pdf/party/content/fareva-party-content-7023.pdf

    https://www.pharmacompass.com/pdf/party/content/fareva-party-content-95206.pdf

    https://www.pharmacompass.com/pdf/party/content/fareva-party-content-32111.pdf

    https://www.pharmacompass.com/pdf/party/content/fareva-party-content-86847.pdf

    https://www.pharmacompass.com/pdf/party/content/fareva-party-content-68710.pdf

    https://www.pharmacompass.com/pdf/party/content/fareva-party-content-96979.pdf

NEWS #PharmaBuzz

read-more
read-more
Our next beauty 2024 exhibitions
Our next beauty 2024 exhibitions

13 Aug 2024

// PRESS RELEASE

https://www.fareva.com/en/news/our-next-beauty-2024-exhibitions

PRESS RELEASE
13 Aug 2024

https://apiject.com/press-announcements/fareva-and-apiject-sign-a-licensing-agreement-to-create-a-france-based-500m-unit-annual-capacity-for-single-dose-prefilled-vaccine-injections/

PRESS RELEASE
10 Dec 2021

https://www.prnewswire.com/news-releases/fareva-and-apiject-sign-a-licensing-agreement-to-create-a-france-based-500m-unit-annual-capacity-for-single-dose-prefilled-vaccine-injections-301441485.html

PRNEWSWIRE
10 Dec 2021

https://www.fareva.com/en/news/fareva-excella-augmente-ses-capacites-de-production-de-produits-hautement-actifs

PRESS RELEASE
11 May 2021

https://extrajournal.net/2021/04/28/fareva-uebernimmt-novartis-standort-mit-wolf-theiss/

EXTRAJOURNALS
28 Apr 2021

https://bioprocessintl.com/bioprocess-insider/facilities-capacity/fareva-to-grow-its-newly-acquired-biomanufacturing-capabilities/

BIOPROCESSINTL
20 Apr 2021

LISTED APIs

read-more
read-more
Fareva’s API division has special technologies for high potent APIs (HPAPIs) down to the OEB-6 level, aseptic crystallization (sterile APIs), Spray Drying etc, with volumes ranging from a few kgs to multi tons production.
Fareva’s Drug Product division offers different technologies: injectables (lyophilized, solution, suspension, vial, amp...
Fareva’s API division has special technologies for high potent APIs (HPAPIs) down to the OEB-6 level, aseptic crystallization (sterile APIs), Spray Drying etc, with volumes ranging from a few kgs to multi tons production.
Fareva’s Drug Product division offers different technologies: injectables (lyophilized, solution, suspension, vial, ampoules, pre-filled syringes), unidoses and multidoses BFS, solids (tablets, hard capsules, powders), semi-solids (cream, gel suppositories) and liquids (oral and external, sprays, aerosols).
Fareva Company Banner

01

Fareva

Fareva’s API division has special technologies for high potent APIs (HPAPIs) down to the OEB-6 level, aseptic crystallization (sterile APIs), Spray Drying etc, with volumes ranging from a few kgs to multi tons production.
Fareva’s Drug Product division offers different technologies: injectables (lyophilized, solution, suspension, vial, ampoules, pre-filled syringes), unidoses and multidoses BFS, solids (tablets, hard capsules, powders), semi-solids (cream, gel suppositories) and liquids (oral and external, sprays, aerosols).

About the Company : Fareva’s API division has special technologies for high potent APIs (HPAPIs) down to the OEB-6 level, aseptic crystallization (sterile APIs), Spray Drying etc, with volumes ranging from a few ...

Fareva Company Banner